rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    HOWL
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Werewolf Therapeutics reports clinical trial data for cancer drugs
      Nov 9Investing.comHOWL
      Werewolf Therapeutics’ Clinical Data for WTX-124 and WTX-330 Presented at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting
      Nov 9Yahoo FinanceHOWL
      Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting
      Oct 30Yahoo FinanceHOWL
      TGTX Stock Rises 60% in 6 Months: Here's What You Should Know

      Detailed price information for Werewolf Therapeutics Inc (HOWL-Q) from The Globe and Mail including charting and trades.

      Oct 13The Globe and MailHOWLTGTX
      Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why
      Oct 13Yahoo FinanceHOWL
      1 Penny Stock That Could Howl Its Way to the Top After a $150 Million Funding Boost

      A merger and a $150 million capital infusion is giving Werewolf's next chapter more firepower, but investors still face risks.

      Aug 26Yahoo FinanceHOWL
      $HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - HOWL, HZO, TYFG and FULC
      Aug 23MorningstarHOWL
      Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News

      Werewolf Therapeutics stock explodes higher on a merger agreement with Ambros Therapeutics. But is there any further upside left in HOWL shares?

      Aug 21Yahoo FinanceHOWL
      12 Health Care Stocks Moving In Friday's Intraday Session
      Aug 21BenzingaARCTHOWLJUNSLSTA
      Gold Moves Higher; US Composite PMI Surges In August
      Aug 21BenzingaFLUXHOWL
      Why is Werewolf Therapeutics stock surging more than 100% today?
      Aug 21Investing.comHOWL
      Why Is Werewolf Therapeutics Stock Gaining Friday? - Werewolf Therapeutics (NASDAQ:HOWL)
      Aug 21BenzingaHOWL
      Israel Englander's HOWL Stock Soars on $500M Deal - Werewolf Therapeutics (NASDAQ:HOWL)
      Aug 21BenzingaHOWL
      Werewolf Therapeutics shares surge 120% after Ambros merger and $150 million financing

      Werewolf Therapeutics Inc (NASDAQ:HOWL) shares soared 120% in premarket trading on Friday after the biotechnology company agreed to merge with Ambros Therapeutics Inc alongside a $150 million private placement. The all-stock combination will create a company centred on the development of neridronate, Ambros Therapeutics’ late-stage drug candidate for Complex Regional Pain Syndrome Type 1 (CRPS-1).

      Aug 21Yahoo FinanceHOWL
      Werewolf Therapeutics stock soars 120% on Ambros merger deal
      Aug 21Investing.comHOWL
      Werewolf Therapeutics to merge with Ambros in $150m deal
      Aug 21Investing.comHOWL
      12 Health Care Stocks Moving In Friday's Pre-Market Session
      Aug 21BenzingaHOWLJUNS
      Werewolf Therapeutics to Merge With Ambros Therapeutics in All-Stock Deal
      Aug 21Yahoo FinanceHOWL
      Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement

      WALTHAM, Mass. and SAN DIEGO, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL) and Ambros Therapeutics, Inc., today announced that they entered into a definitive merger agreement to combine the companies in an...

      Aug 21BarchartHOWL

      This is the newest page. Registered accounts read further back.